GLP1R and asthma: Kimura et al. report that in the Japanese national administrative database, among 137,173 new oral antidiabetic drugs users with history of asthma, people treated with GLP-1 receptor agonists had a hazard ratio of 1.14 (95% CI: 1.01–1.28) for exacerbations requiring systemic glucocorticoid therapy compared to metformin [48].